Evidence-Based Medicine Guidelines
Beta-blockers for hyperthyreoidism
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Beta-blockers for Hyperthyreoidism." Evidence-Based Medicine Guidelines, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/452585/all/Beta_blockers_for_hyperthyreoidism.
Beta-blockers for hyperthyreoidism. Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/EBMG/452585/all/Beta_blockers_for_hyperthyreoidism. Accessed April 27, 2025.
Beta-blockers for hyperthyreoidism. (2025). In Evidence-Based Medicine Guidelines. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/EBMG/452585/all/Beta_blockers_for_hyperthyreoidism
Beta-blockers for Hyperthyreoidism [Internet]. In: Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. [cited 2025 April 27]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/452585/all/Beta_blockers_for_hyperthyreoidism.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Beta-blockers for hyperthyreoidism
ID - 452585
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/452585/all/Beta_blockers_for_hyperthyreoidism
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
